Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Asad

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 27, 2026
Human papillomavirus: role of HPV2 and HPV9 in reducing the burden of cervical cancer in sub-Saharan AfricaChristian Tague, Ayesha Junaid, Yousra Anwar, et al.
Trials|March 26, 2021
Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview studyGisell Castillo, Manoj Lalu, Sarah Asad, et al.
JCO Oncology Practice|October 4, 2021
Identifying Strategies for Robust Survivorship Program Implementation: A Qualitative Analysis of Cancer ProgramsSoohyun Hwang, Burcu Bozkurt, Tamara Huson, et al.
BMJ Open|March 20, 2021
Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trialGisell Castillo, Manoj M Lalu, Sarah Asad, et al.
Research Involvement and Engagement|October 19, 2020
Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trialsMadison Foster, Dean A Fergusson, Terry Hawrysh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2021
Sociodemographic Factors Associated With Rapid Relapse in Triple-Negative Breast Cancer: A Multi-Institution StudySarah Asad, Carlos H Barcenas, Richard J Bleicher, et al.
JCO Precision Oncology|December 1, 2021
Association of 17q22 Amplicon Via Cell-Free DNA With Platinum Chemotherapy Response in Metastatic Triple-Negative Breast CancerKatharine A Collier, Sarah Asad, David Tallman, et al.
The Journal of Nutrition|September 14, 2024
Association between Inflammatory Dietary Pattern and Mammographic FeaturesShadi Azam, Sarah Asad, Saurabh D Chitnis, et al.
Breast (Edinburgh, Scotland)|January 21, 2023
Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort studyAdith Abraham, Carlos H Barcenas, Richard J Bleicher, et al.
Clinical Breast Cancer|October 22, 2019
Aggressive Subsets of Metastatic Triple Negative Breast CancerJasneet Singh, Sarah Asad, Yiqing Zhang, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 27, 2026
Human papillomavirus: role of HPV2 and HPV9 in reducing the burden of cervical cancer in sub-Saharan AfricaChristian Tague, Ayesha Junaid, Yousra Anwar, et al.
Trials|March 26, 2021
Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview studyGisell Castillo, Manoj Lalu, Sarah Asad, et al.
JCO Oncology Practice|October 4, 2021
Identifying Strategies for Robust Survivorship Program Implementation: A Qualitative Analysis of Cancer ProgramsSoohyun Hwang, Burcu Bozkurt, Tamara Huson, et al.
BMJ Open|March 20, 2021
Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trialGisell Castillo, Manoj M Lalu, Sarah Asad, et al.
Research Involvement and Engagement|October 19, 2020
Partnering with patients to get better outcomes with chimeric antigen receptor T-cell therapy: towards engagement of patients in early phase trialsMadison Foster, Dean A Fergusson, Terry Hawrysh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2021
Sociodemographic Factors Associated With Rapid Relapse in Triple-Negative Breast Cancer: A Multi-Institution StudySarah Asad, Carlos H Barcenas, Richard J Bleicher, et al.
JCO Precision Oncology|December 1, 2021
Association of 17q22 Amplicon Via Cell-Free DNA With Platinum Chemotherapy Response in Metastatic Triple-Negative Breast CancerKatharine A Collier, Sarah Asad, David Tallman, et al.
The Journal of Nutrition|September 14, 2024
Association between Inflammatory Dietary Pattern and Mammographic FeaturesShadi Azam, Sarah Asad, Saurabh D Chitnis, et al.
Breast (Edinburgh, Scotland)|January 21, 2023
Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort studyAdith Abraham, Carlos H Barcenas, Richard J Bleicher, et al.
Clinical Breast Cancer|October 22, 2019
Aggressive Subsets of Metastatic Triple Negative Breast CancerJasneet Singh, Sarah Asad, Yiqing Zhang, et al.
Pageof 4